GlaxoSmithKline reported 2211.1B in Debt for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Alcon AG ALC:SW 4.18B 266.49M
Amgen AMGN:US $ 36522M 332M
AstraZeneca AZN:LN 2425311.81M 57309.55M
Bayer BAYN:GR € 44634M 2087M
Biogen BIIB:US $ 7277.2M 2M
Bristol Myers Squibb BMY:US $ 42060M 2912M
Eli Lilly And LLY:US $ 16813.8M 305M
Fresenius FRE:GR € 28368M 1157M
Fresenius Medical Care FME:GR € 13659M 315.63M
Galapagos GLPG:NA € 24.05M 1.3M
Genmab GEN:DC DK 634M 218M
Glaxosmithkline GSK:US $ 22111M 11217M
GlaxoSmithKline GSK:LN 2211100M 1121700M
Hikma Pharmaceutical HIK:LN 127.39B 64.86B
Lonza Group LONN:SW 2.4B 0
Merck MRK:GR € 11803M 1172M
Novartis NOVN:VX SF 31031M 244M
Orion ORNBV:FH € 253.6M 121.7M
Philips PHIA:NA € 8001M 994M
Recordati REC:IM € 1827.9M 157.02M
Regeneron Pharmaceuticals REGN:US $ 2700.7M 0.3M